Description: Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, California.
Home Page: www.vivani.com
VANI Technical Analysis
5858 Horton Street
EmeryVille,
CA
94608
United States
Phone:
818 833 5000
Officers
| Name | Title |
|---|---|
| Mr. Adam Mendelsohn Ph.D. | Co-Founder, Chairman & CEO |
| Mr. Truc Le M.B.A. | Chief Operations Officer |
| Dr. Lisa E. Porter M.D. | Chief Medical Officer |
| Mr. Donald Dwyer M.B.A. | Chief Bus. Officer |
| Dr. Kayte Fischer Ph.D. | Co-Founder |
| Ms. Brigid Ann Makes | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.5904 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2014-11-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |